Stock Track | Amprius Technologies (AMPX) Soars 12% on Strong Q3 Earnings Beat and Positive Analyst Ratings

Stock Track11-08

Shares of Amprius Technologies Operating Inc (AMPX) are soaring 12.08% in intraday trading, building on the pre-market momentum following the release of the company's impressive third-quarter earnings report. The silicon anode battery technology firm significantly outperformed analyst expectations, demonstrating robust growth and improved financial performance.

Amprius Technologies reported a quarterly adjusted loss of 3 cents per share, beating the Wall Street consensus estimate of a 6-cent loss. This represents a substantial improvement from the 10-cent loss per share reported in the same quarter last year. More impressively, the company's revenue skyrocketed by 172.8% to $21.43 million, far exceeding analysts' expectations of $16.81 million.

The strong earnings report has also prompted positive reactions from analysts. Roth Capital raised its price target on Amprius Technologies to $16 from $14, maintaining a Buy rating. Additionally, Northland Securities reiterated a Buy rating with a price target of $20, while Cantor Fitzgerald maintained an Overweight rating on the stock. These positive analyst actions further fueled investor enthusiasm, contributing to the stock's significant surge today.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment